| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.091 | 0.04 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.04 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.05 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.06 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.28 | 0.06 |